<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00617175</url>
  </required_header>
  <id_info>
    <org_study_id>ADVANCE III</org_study_id>
    <secondary_id>ADVANCE III</secondary_id>
    <nct_id>NCT00617175</nct_id>
  </id_info>
  <brief_title>Avoid DeliVering TherApies for Non-sustained Arrhythmias in ICD PatiEnts III</brief_title>
  <acronym>ADVANCEIII</acronym>
  <official_title>ADVANCE III: Avoid DeliVering TherApies for Non-sustained Arrhythmias in ICD PatiEnts III</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic Bakken Research Center</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medtronic Bakken Research Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To demonstrate a reduction in the number of ventricular therapies (ATP and Shocks) delivered
      for treating spontaneous arrhythmia episodes with a fast cycle length (CL≤ 320ms) as a
      consequence of self-termination and better arrhythmia discrimination due to a greater number
      of R-R intervals necessary to detect ventricular events.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Primary Objective:

      The primary objective is to demonstrate a 20% reduction of ventricular therapies (ATP and
      Shocks) delivered for treating spontaneous arrhythmia episodes with a fast cycle length (CL ≤
      320 ms) by choosing a number of 30 out of 40 intervals to detect (NID) compared to a NID of
      18 out of 24 in subjects with either Class I or IIA indication for ICD implantation,
      regardless of cardiac resynchronization capabilities.

      Secondary Objectives:

        1. Evaluate the percent reduction in the number of shocks delivered per subject for
           treating spontaneous episodes with a fast cycle length (CL ≤ 320 ms) and for spontaneous
           ventricular episodes.

        2. Evaluate the efficacy of ATP in successfully treating spontaneous ventricular episodes
           (CL: 200ms-320ms) for subjects in primary and secondary prevention in both arms of the
           study.

        3. Evaluate acceleration rate or degeneration into VF of spontaneous episodes (CL of
           200ms-320ms) due to ATP therapy in the two study arms.

        4. Compare the likelihood of syncopal events associated with spontaneous episodes with a
           fast cycle length (CL ≤ 320 ms).

        5. Describe the economic impact and the quality of life consequences.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2008</start_date>
  <completion_date type="Actual">February 2012</completion_date>
  <primary_completion_date type="Actual">December 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>For the Primary Endpoint the Reduction of Ventricular Therapies (ATP and Shocks) Delivered for Treating Fast Spontaneous Arrhythmia Episodes Was Measured.</measure>
    <time_frame>From enrollment to study completion or exit whichever occured first</time_frame>
    <description>for each patient, the exposure time was calculated as the period between randomization and until study completion or exit whichever occured first. Exposure times for all patients were then summed.
The rate of therapies was calculated as the sum of all therapies delivered in the study (for each arm) over the sum of exposure times * 100.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluate the Percent Reduction in the Number of Shocks Delivered Per Subject for Treating Spontaneous Episodes With a Fast Cycle Length (CL &lt; 320 ms) and for Spontaneous Ventricular Episodes.</measure>
    <time_frame>end of study</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">1902</enrollment>
  <condition>Heart Disease</condition>
  <arm_group>
    <arm_group_label>Long NID</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Programming a number of 30 out of 40 intervals to detect (NID)ventricular arrhythmia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Short NID</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Programming a number of 18 out of 24 intervals to detect (NID)ventricular arrhythmia</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Implantable Defibrillator</intervention_name>
    <description>Number of 30 out of 40 intervals to detect (NID)Fast Ventricular Tachycardia</description>
    <arm_group_label>Long NID</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Implantable Defibrillator</intervention_name>
    <description>number of 18 out of 24 intervals to detect (NID)Fast Ventricular Tachycardia</description>
    <arm_group_label>Short NID</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Either ICD or CRT+ICD indications (Class I-IIA) according to the current AHA / ACC /
             ESC guidelines.

          -  Previous implant of a Medtronic device including &quot;ATP During Charging&quot; feature for 15
             days at the maximum.

        Exclusion Criteria:

          -  ICD replacements and upgrading.

          -  Brugada Syndrome, Long QT and HCM patients

          -  Ventricular tachyarrhythmia associated with reversible cause.

          -  Other electrical implantable devices (Neurostimulators, etc.).

          -  Subject's life expectancy less than 1 year.

          -  Subject on heart transplant list which is expected in less than 1 year.

          -  Subject is &lt;18 years of age, or the subject is under a minimum age that is required as
             defined by local law

          -  Women who are pregnant or women of childbearing potential who are not on a reliable
             form of birth control.

          -  Unwillingness or inability to provide written informed consent.

          -  Enrolment in, or intention to participate in, another clinical trial.

          -  Inaccessibility to come to the study center for the follow-up visits.

          -  Mechanical tricuspid valve.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jorg O. Schwab, MD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Bonn, Bonn, Germany</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Maurizio Gasparini, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Humanitas Hospital, Milano Italy</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Maurizio Lunati, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Niguarda Hospital, Milano, Italy</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Bernd Lemke, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Klinikum Lüdenscheid, Lüdenscheid, Germany</affiliation>
  </overall_official>
  <overall_official>
    <last_name>João Sousa, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>H. Santa Maria - Lisbon - Portugal</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Andrzej Okreglicki, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Cape Town, Cape Town, South Africa</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Angel Arenal, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Gregorio Marañón, Madrid, Spain</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Maurits Wijffels, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>St. Antonius hospital - NIEUWEGEIN, The Netherlands</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hopital St-Joseph</name>
      <address>
        <city>Gilly</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Brugmann</name>
      <address>
        <city>Laken</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHR La Citadelle Liege</name>
      <address>
        <city>Liege</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHR Namur</name>
      <address>
        <city>Namur</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>AZ Nikolaas</name>
      <address>
        <city>Sint-Niklaas</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>KAS Gentofte</name>
      <address>
        <city>Hellerup</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Odense Universitets Hospital</name>
      <address>
        <city>Odense</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Turku University Central Hospital</name>
      <address>
        <city>Turku</city>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Michalon- CHU Grenoble</name>
      <address>
        <city>Grenoble</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NCN Nantes</name>
      <address>
        <city>Nantes Cedex 2</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Nantes - Hôpital Guillaume et René Laënnec</name>
      <address>
        <city>Nantes</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopital de la Pitie Salpetriere</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Pau</name>
      <address>
        <city>Pau</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Hôpital de Pontchaillou Rennes</name>
      <address>
        <city>Rennes</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CH Rangueil Toulouse</name>
      <address>
        <city>Toulouse</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique Pasteur</name>
      <address>
        <city>Toulouse</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>RWTH Aachen</name>
      <address>
        <city>Aachen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Bonn</name>
      <address>
        <city>Bonn</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kardiologisches Zentrum an der Klinik Rotes Kreuz</name>
      <address>
        <city>Frankfurt am Main</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SRH Wald-Klinikum Gera gGmbH</name>
      <address>
        <city>Gera</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätskliniken des Saarlandes</name>
      <address>
        <city>Homburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Lüdenscheid</name>
      <address>
        <city>Lüdenscheid</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Dorothea Christiane Erxleben Quedlinburg</name>
      <address>
        <city>Quedlinburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universität Rostock- Medizinische Fakultät</name>
      <address>
        <city>Rostock</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Diakoniekrankenhaus Rotenburg</name>
      <address>
        <city>Rotenburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Semmelweis University AOK</name>
      <address>
        <city>Budapest</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Zala County Hospital</name>
      <address>
        <city>Zalaegerszeg</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Presidio Ospedaliero di Venere</name>
      <address>
        <city>Carbonara</city>
        <state>Bari</state>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda.Ospedaliera.G.M. Lancisi</name>
      <address>
        <city>Ancona</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera G. Rummo</name>
      <address>
        <city>Benevento</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cliniche Gavazzeni</name>
      <address>
        <city>Bergamo</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Stab. Ospedaliero Di Summa-Perrino - Brindisi</name>
      <address>
        <city>Brindisi</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Casa di Cura Mater Domini</name>
      <address>
        <city>Castellanza</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Pugliese e Ciaccio</name>
      <address>
        <city>Catanzaro</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>A.O. Santa Croce e Carle</name>
      <address>
        <city>Cuneo</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ente Ospedaliero Ospedali Galliera - Genova</name>
      <address>
        <city>Genova</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Maggiore di Lodi</name>
      <address>
        <city>Lodi</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Istituto Ca' Granda-Niguarda</name>
      <address>
        <city>Milano</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>San Carlo Borromeo</name>
      <address>
        <city>Milano</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nuovo Osp. Civile S. Agostino</name>
      <address>
        <city>Modena</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>P.O. di Montebelluna</name>
      <address>
        <city>Montebelluna</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale S. Giacomo</name>
      <address>
        <city>Novi Ligure</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Policlinico S. Matteo</name>
      <address>
        <city>Pavia</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Osp. S. Maria degli Angeli - Pordenone</name>
      <address>
        <city>Pordenone</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Misericordia e Dolce</name>
      <address>
        <city>Prato</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda Complesso Ospedaliero San Filippo Neri</name>
      <address>
        <city>Roma</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Sandro Pertini</name>
      <address>
        <city>Roma</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Sant Eugenio</name>
      <address>
        <city>Roma</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Istituto Clinico Humanitas</name>
      <address>
        <city>Rozzano</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Osp. S. Giovanni di Dio e Ruggi dAragona</name>
      <address>
        <city>Salerno</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>AZ. Osp. Ordine Mauriziano</name>
      <address>
        <city>Torino</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>A.O. S.Maria della Misericordia</name>
      <address>
        <city>Udine</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ULSS N.6 S. Bortolo - Vicenza</name>
      <address>
        <city>Vicenza</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medisch Spectrum Twente</name>
      <address>
        <city>Enschede</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Antonius Ziekenhuis Nieuwegein</name>
      <address>
        <city>Nieuwegein</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Zoz Mswia</name>
      <address>
        <city>Bialystok</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Garcia Orta, SA</name>
      <address>
        <city>Almada</city>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital de Santa Maria</name>
      <address>
        <city>Lisboa</city>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital de Santa Marta</name>
      <address>
        <city>Lisboa</city>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Geral de Santo António</name>
      <address>
        <city>Porto</city>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tyumen Cardiology Center</name>
      <address>
        <city>Tyumen</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>King Fahd Armed Forces Hospital</name>
      <address>
        <city>Jeddah</city>
        <country>Saudi Arabia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>King Khalid Univ. Hospital - King Saud University</name>
      <address>
        <city>Riyadh</city>
        <country>Saudi Arabia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bloemfontein Medi-Clinic</name>
      <address>
        <city>Bloemfontein</city>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Christiaan Barnard Memorial Hospital</name>
      <address>
        <city>Cape Town</city>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Cape Town - Groote Schuur Hospital</name>
      <address>
        <city>Cape Town</city>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vincent Pallotti Hospital</name>
      <address>
        <city>Cape Town</city>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Milpark Hospital</name>
      <address>
        <city>Johannesburg</city>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sunninghill Hospital</name>
      <address>
        <city>Johannesburg</city>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UNITAS Hospital</name>
      <address>
        <city>Pretoria</city>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital General Universitario de Alicante</name>
      <address>
        <city>Alicante</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital de Basurto - Bilbao</name>
      <address>
        <city>Bilbao</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital General Yagüe</name>
      <address>
        <city>Burgos</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital General San Pedro de Alcantara</name>
      <address>
        <city>Caceres</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital General de Ciudad Real</name>
      <address>
        <city>Ciudad Real</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital de Donostia</name>
      <address>
        <city>Donostia-San Sebastian</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Virgen de las Nieves</name>
      <address>
        <city>Granada</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>H. Ramón y Cajal</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital General Universitario Gregorio Marañón</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Puerta de Hierro Majadahonda</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario La Paz</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Clinico de Malaga - Virgen de la Victoria</name>
      <address>
        <city>Malaga</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Son Dureta</name>
      <address>
        <city>Palma Mallorca</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de San Juan</name>
      <address>
        <city>San Juan de Alicante</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Ntra. Sra. de la Candelaria</name>
      <address>
        <city>Santa Cruz de Tenerife</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de Canarias</name>
      <address>
        <city>Santa Cruz de Tenerife</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Virgen de La Salud</name>
      <address>
        <city>Toledo</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Arnau de Vilanova</name>
      <address>
        <city>Valencia</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Clinico Universitario de Valencia</name>
      <address>
        <city>Valencia</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chuvi-Xeral-Cíes</name>
      <address>
        <city>Vigo</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital de Txagorritxu</name>
      <address>
        <city>Vitoria / Gasteiz</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Denmark</country>
    <country>Finland</country>
    <country>France</country>
    <country>Germany</country>
    <country>Hungary</country>
    <country>Italy</country>
    <country>Netherlands</country>
    <country>Poland</country>
    <country>Portugal</country>
    <country>Russian Federation</country>
    <country>Saudi Arabia</country>
    <country>South Africa</country>
    <country>Spain</country>
  </location_countries>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 4, 2008</study_first_submitted>
  <study_first_submitted_qc>February 14, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 15, 2008</study_first_posted>
  <results_first_submitted>August 30, 2012</results_first_submitted>
  <results_first_submitted_qc>January 21, 2013</results_first_submitted_qc>
  <results_first_posted type="Estimate">February 25, 2013</results_first_posted>
  <last_update_submitted>March 23, 2016</last_update_submitted>
  <last_update_submitted_qc>March 23, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 24, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Implantable Cardiac Defibrillator</keyword>
  <keyword>therapies reduction</keyword>
  <keyword>Shocks</keyword>
  <keyword>Quality of Life</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Short NID</title>
          <description>Programming a number of 18 out of 24 intervals to detect (NID)ventricular arrhythmia</description>
        </group>
        <group group_id="P2">
          <title>Long NID</title>
          <description>Programming a number of 30 out of 40 intervals to detect (NID)ventricular arrhythmia</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="954"/>
                <participants group_id="P2" count="948"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="954"/>
                <participants group_id="P2" count="948"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Short NID</title>
          <description>Programming a number of 18 out of 24 intervals to detect (NID)ventricular arrhythmia</description>
        </group>
        <group group_id="B2">
          <title>Long NID</title>
          <description>Programming a number of 30 out of 40 intervals to detect (NID)ventricular arrhythmia</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="954"/>
            <count group_id="B2" value="948"/>
            <count group_id="B3" value="1902"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="391"/>
                    <measurement group_id="B2" value="390"/>
                    <measurement group_id="B3" value="781"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="563"/>
                    <measurement group_id="B2" value="558"/>
                    <measurement group_id="B3" value="1121"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="65.5" spread="11.1"/>
                    <measurement group_id="B2" value="65.4" spread="11.0"/>
                    <measurement group_id="B3" value="65.47" spread="11.04"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="151"/>
                    <measurement group_id="B2" value="153"/>
                    <measurement group_id="B3" value="304"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="803"/>
                    <measurement group_id="B2" value="795"/>
                    <measurement group_id="B3" value="1598"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Germany</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="52"/>
                    <measurement group_id="B2" value="60"/>
                    <measurement group_id="B3" value="112"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Spain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="196"/>
                    <measurement group_id="B2" value="196"/>
                    <measurement group_id="B3" value="392"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Italy</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="448"/>
                    <measurement group_id="B2" value="429"/>
                    <measurement group_id="B3" value="877"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hungary</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Netherlands</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Belgium</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                    <measurement group_id="B2" value="22"/>
                    <measurement group_id="B3" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>France</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="61"/>
                    <measurement group_id="B2" value="62"/>
                    <measurement group_id="B3" value="123"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Russian Federation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Saudi Arabia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="45"/>
                    <measurement group_id="B2" value="45"/>
                    <measurement group_id="B3" value="90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Denmark</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Finland</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>South Africa</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="32"/>
                    <measurement group_id="B2" value="24"/>
                    <measurement group_id="B3" value="56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Poland</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Portugal</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                    <measurement group_id="B2" value="30"/>
                    <measurement group_id="B3" value="53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>For the Primary Endpoint the Reduction of Ventricular Therapies (ATP and Shocks) Delivered for Treating Fast Spontaneous Arrhythmia Episodes Was Measured.</title>
        <description>for each patient, the exposure time was calculated as the period between randomization and until study completion or exit whichever occured first. Exposure times for all patients were then summed.
The rate of therapies was calculated as the sum of all therapies delivered in the study (for each arm) over the sum of exposure times * 100.</description>
        <time_frame>From enrollment to study completion or exit whichever occured first</time_frame>
        <population>For the primary endpoint analysis, only patients with at least a device data record were considered.</population>
        <group_list>
          <group group_id="O1">
            <title>NID 18/24</title>
            <description>standard number of interval to detect ventricular arrhythmias</description>
          </group>
          <group group_id="O2">
            <title>NID 30/40</title>
            <description>Prolonged number of interval to detect ventricular arrhythmias</description>
          </group>
        </group_list>
        <measure>
          <title>For the Primary Endpoint the Reduction of Ventricular Therapies (ATP and Shocks) Delivered for Treating Fast Spontaneous Arrhythmia Episodes Was Measured.</title>
          <description>for each patient, the exposure time was calculated as the period between randomization and until study completion or exit whichever occured first. Exposure times for all patients were then summed.
The rate of therapies was calculated as the sum of all therapies delivered in the study (for each arm) over the sum of exposure times * 100.</description>
          <population>For the primary endpoint analysis, only patients with at least a device data record were considered.</population>
          <units>rate of therapies per 100 patient-years</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="891"/>
                <count group_id="O2" value="876"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="67.1" lower_limit="61.7" upper_limit="72.9"/>
                    <measurement group_id="O2" value="41.9" lower_limit="27.6" upper_limit="46.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <method>Negative binomial regression</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Evaluate the Percent Reduction in the Number of Shocks Delivered Per Subject for Treating Spontaneous Episodes With a Fast Cycle Length (CL &lt; 320 ms) and for Spontaneous Ventricular Episodes.</title>
        <time_frame>end of study</time_frame>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse events collection started at day 0 after enrollment until study completion or exit whichever occured first.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Short NID</title>
          <description>Programming a number of 18 out of 24 intervals to detect (NID)ventricular arrhythmia</description>
        </group>
        <group group_id="E2">
          <title>Long NID</title>
          <description>Programming a number of 30 out of 40 intervals to detect (NID)ventricular arrhythmia</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="300" subjects_at_risk="954"/>
                <counts group_id="E2" subjects_affected="258" subjects_at_risk="948"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Thromboembolic Events</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="954"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="948"/>
              </event>
              <event>
                <sub_title>hypotension</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="954"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="948"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="954"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="948"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Lead Dislodgment</sub_title>
                <counts group_id="E1" subjects_affected="27" subjects_at_risk="954"/>
                <counts group_id="E2" subjects_affected="20" subjects_at_risk="948"/>
              </event>
              <event>
                <sub_title>Worsening heart failure</sub_title>
                <counts group_id="E1" subjects_affected="95" subjects_at_risk="954"/>
                <counts group_id="E2" subjects_affected="83" subjects_at_risk="948"/>
              </event>
              <event>
                <sub_title>System Dysfunction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="954"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="948"/>
              </event>
              <event>
                <sub_title>Inappropriate Tachyarrhythmia Therapy</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="954"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="948"/>
              </event>
              <event>
                <sub_title>Acute Myocardial Infarction</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="954"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="948"/>
              </event>
              <event>
                <sub_title>Coronary Artery disease</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="954"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="948"/>
              </event>
              <event>
                <sub_title>Elevated Threshold</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="954"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="948"/>
              </event>
              <event>
                <sub_title>All cause syncope</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="954"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="948"/>
              </event>
              <event>
                <sub_title>Cardiogenic shock</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="954"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="948"/>
              </event>
              <event>
                <sub_title>Ventricular Arrhythmia</sub_title>
                <counts group_id="E1" subjects_affected="24" subjects_at_risk="954"/>
                <counts group_id="E2" subjects_affected="22" subjects_at_risk="948"/>
              </event>
              <event>
                <sub_title>Atrial Arrhthmias</sub_title>
                <counts group_id="E1" subjects_affected="22" subjects_at_risk="954"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="948"/>
              </event>
              <event>
                <sub_title>Angina</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="954"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="948"/>
              </event>
              <event>
                <sub_title>Extracardiac Stimulation</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="954"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="948"/>
              </event>
              <event>
                <sub_title>Dyspnea</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="954"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="948"/>
              </event>
              <event>
                <sub_title>bradycardia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="954"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="948"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Neoplasia</sub_title>
                <counts group_id="E1" subjects_affected="19" subjects_at_risk="954"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="948"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Musculoskeletal diseases</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="954"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="948"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Renal Failure</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="954"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="948"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="954"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="948"/>
              </event>
              <event>
                <sub_title>Chronic obstructive pulmonary disease</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="954"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="948"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Pocket Hematoma</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="954"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="948"/>
              </event>
              <event>
                <sub_title>Post Surgical Infection</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="954"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="948"/>
              </event>
              <event>
                <sub_title>epicardial LV implant</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="954"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="948"/>
              </event>
              <event>
                <sub_title>Pericardial Effusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="954"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="948"/>
              </event>
              <event>
                <sub_title>Pocket Infection</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="954"/>
                <counts group_id="E2" subjects_affected="17" subjects_at_risk="948"/>
              </event>
              <event>
                <sub_title>Pneumothorax</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="954"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="948"/>
              </event>
              <event>
                <sub_title>Device migration</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="954"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="948"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="954"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="948"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Laura Manotta</name_or_title>
      <organization>MEDTRONIC Clinical Research Institute</organization>
      <phone>+39022413.1</phone>
      <email>laura.manotta@medtronic.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

